Basel Medical Group Ltd (BMGL)

Basel Medical Group Income Statement

Financials in millions SGD. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Operating Revenue	10.05	9.7	10.66
Other Revenue	0.02	0.05	-
Revenue	10.07	9.75	10.66
Revenue Growth (YoY)	3.32%	-8.55%	-
Cost of Revenue	5.89	5.58	2.72
Gross Profit	4.18	4.16	7.94
Selling, General & Admin	0.7	1.05	5.78
Other Operating Expenses	0.81	0.55	-0.31
Operating Expenses	2.04	2.16	5.48
Operating Income	2.14	2	2.46
Interest Expense	-0.18	-0.24	-0.32
Interest & Investment Income	-	0.3	0.25
Other Non Operating Income (Expenses)	0.44	0.07	-
Pretax Income	2.4	2.13	2.39
Income Tax Expense	0.33	0.35	0.41
Net Income	2.07	1.78	1.98
Net Income to Common	2.07	1.78	1.98
Net Income Growth	16.23%	-9.84%	-
Shares Outstanding (Basic)	16	16	16
Shares Outstanding (Diluted)	16	16	16
EPS (Basic)	0.13	0.11	0.12
EPS (Diluted)	0.13	0.11	0.12
EPS Growth	16.23%	-9.84%	-
Free Cash Flow	2.5	2.59	2.7
Free Cash Flow Per Share	0.15	0.16	0.17
Gross Margin	41.54%	42.71%	74.48%
Operating Margin	21.24%	20.55%	23.09%
Profit Margin	20.58%	18.30%	18.56%
Free Cash Flow Margin	24.84%	26.61%	25.37%
EBITDA	2.17	2.03	2.48
EBITDA Margin	21.54%	20.86%	23.30%
D&A For EBITDA	0.03	0.03	0.02
EBIT	2.14	2	2.46
EBIT Margin	21.24%	20.55%	23.09%
Effective Tax Rate	13.80%	16.34%	17.12%

Updated Nov 4, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q